Autoantibodies in Morphea: An Update

Sangita Khatri, Kathryn S. Torok, Emily Mirizio, Christopher Liu, Kira Astakhova

Research output: Contribution to journalJournal articleResearchpeer-review

91 Downloads (Pure)

Abstract

Skin autoimmune conditions belong to a larger group of connective tissue diseases and primarily affect the skin, but might also involve underlying tissues, such as fat tissue, muscle, and bone. Autoimmune antibodies (autoantibodies) play a role in autoimmune skin diseases, such as localized scleroderma also termed morphea, and systemic scleroderma, also called systemic sclerosis (SSc). The detailed studies on the biological role of autoantibodies in autoimmune skin diseases are limited. This results in a few available tools for effective diagnosis and management of autoimmune skin diseases. This review aims to provide an update on the detection and most recent research on autoantibodies in morphea. Several recent studies have indicated the association of autoantibody profiles with disease subtypes, damage extent, and relapse potential, opening up exciting new possibilities for personalized disease management. We discuss the role of existing autoantibody tests in morphea management and the most recent studies on morphea pathogenesis. We also provide an update on novel autoantibody biomarkers for the diagnosis and study of morphea.
Original languageEnglish
Article number1487
JournalFrontiers in Immunology
Volume10
Number of pages12
ISSN1664-3224
DOIs
Publication statusPublished - 2019

Keywords

  • Skin autoimmunity
  • Morphea
  • Autoantibody
  • Diagnostics
  • Personalized management

Cite this

Khatri, Sangita ; Torok, Kathryn S. ; Mirizio, Emily ; Liu, Christopher ; Astakhova, Kira. / Autoantibodies in Morphea: An Update. In: Frontiers in Immunology. 2019 ; Vol. 10.
@article{afae21dee34147fcb1ed663d5b06ae1d,
title = "Autoantibodies in Morphea: An Update",
abstract = "Skin autoimmune conditions belong to a larger group of connective tissue diseases and primarily affect the skin, but might also involve underlying tissues, such as fat tissue, muscle, and bone. Autoimmune antibodies (autoantibodies) play a role in autoimmune skin diseases, such as localized scleroderma also termed morphea, and systemic scleroderma, also called systemic sclerosis (SSc). The detailed studies on the biological role of autoantibodies in autoimmune skin diseases are limited. This results in a few available tools for effective diagnosis and management of autoimmune skin diseases. This review aims to provide an update on the detection and most recent research on autoantibodies in morphea. Several recent studies have indicated the association of autoantibody profiles with disease subtypes, damage extent, and relapse potential, opening up exciting new possibilities for personalized disease management. We discuss the role of existing autoantibody tests in morphea management and the most recent studies on morphea pathogenesis. We also provide an update on novel autoantibody biomarkers for the diagnosis and study of morphea.",
keywords = "Skin autoimmunity, Morphea, Autoantibody, Diagnostics, Personalized management",
author = "Sangita Khatri and Torok, {Kathryn S.} and Emily Mirizio and Christopher Liu and Kira Astakhova",
year = "2019",
doi = "10.3389/fimmu.2019.01487",
language = "English",
volume = "10",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Research Foundation",

}

Autoantibodies in Morphea: An Update. / Khatri, Sangita; Torok, Kathryn S.; Mirizio, Emily; Liu, Christopher; Astakhova, Kira.

In: Frontiers in Immunology, Vol. 10, 1487, 2019.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Autoantibodies in Morphea: An Update

AU - Khatri, Sangita

AU - Torok, Kathryn S.

AU - Mirizio, Emily

AU - Liu, Christopher

AU - Astakhova, Kira

PY - 2019

Y1 - 2019

N2 - Skin autoimmune conditions belong to a larger group of connective tissue diseases and primarily affect the skin, but might also involve underlying tissues, such as fat tissue, muscle, and bone. Autoimmune antibodies (autoantibodies) play a role in autoimmune skin diseases, such as localized scleroderma also termed morphea, and systemic scleroderma, also called systemic sclerosis (SSc). The detailed studies on the biological role of autoantibodies in autoimmune skin diseases are limited. This results in a few available tools for effective diagnosis and management of autoimmune skin diseases. This review aims to provide an update on the detection and most recent research on autoantibodies in morphea. Several recent studies have indicated the association of autoantibody profiles with disease subtypes, damage extent, and relapse potential, opening up exciting new possibilities for personalized disease management. We discuss the role of existing autoantibody tests in morphea management and the most recent studies on morphea pathogenesis. We also provide an update on novel autoantibody biomarkers for the diagnosis and study of morphea.

AB - Skin autoimmune conditions belong to a larger group of connective tissue diseases and primarily affect the skin, but might also involve underlying tissues, such as fat tissue, muscle, and bone. Autoimmune antibodies (autoantibodies) play a role in autoimmune skin diseases, such as localized scleroderma also termed morphea, and systemic scleroderma, also called systemic sclerosis (SSc). The detailed studies on the biological role of autoantibodies in autoimmune skin diseases are limited. This results in a few available tools for effective diagnosis and management of autoimmune skin diseases. This review aims to provide an update on the detection and most recent research on autoantibodies in morphea. Several recent studies have indicated the association of autoantibody profiles with disease subtypes, damage extent, and relapse potential, opening up exciting new possibilities for personalized disease management. We discuss the role of existing autoantibody tests in morphea management and the most recent studies on morphea pathogenesis. We also provide an update on novel autoantibody biomarkers for the diagnosis and study of morphea.

KW - Skin autoimmunity

KW - Morphea

KW - Autoantibody

KW - Diagnostics

KW - Personalized management

U2 - 10.3389/fimmu.2019.01487

DO - 10.3389/fimmu.2019.01487

M3 - Journal article

C2 - 31354701

VL - 10

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

M1 - 1487

ER -